Company intelligence / Profile preview

Seqera Labs

Ownership: Private
Development stage: Commercial

Overview

Seqera provides industry-standard workflow orchestration and data analysis platforms for life sciences, enabling scalable, reproducible research in genomics, drug discovery, diagnostics, and public health. Its tools have been pivotal in large-scale projects such as Covid variant detection and are used by leading pharmaceutical companies worldwide[1][3][6].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Genomics England (for NHS genomic medicine service)AstraZenecaJanssen PharmaceuticalsOxford Nanopore Technologies

Beyond the preview

Go deeper on Seqera Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seqera Labs.

Explore the full profile